Capricor Therapeutics
CAPR
#7985
Rank
NZ$0.50 B
Marketcap
NZ$10.98
Share price
-4.36%
Change (1 day)
-57.33%
Change (1 year)

Capricor Therapeutics (CAPR) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$25.11 Million

According to Capricor Therapeutics 's latest financial reports the company's total debt is NZ$25.11 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Capricor Therapeutics - Total debt on balance sheet (from 2002 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$2.57 M-27.22%
2023-12-31NZ$3.53 M-12.32%
2022-12-31NZ$4.03 M-4.05%
2021-12-31NZ$4.2 M853.02%
2020-12-31NZ$0.44 M
2017-12-31N/A-100%
2016-12-31NZ$20.07 M50.07%
2015-12-31NZ$13.37 M14.48%
2014-12-31NZ$11.68 M142.39%
2013-12-31NZ$4.82 M
2006-12-31NZ$0.17 M74.31%
2005-12-31NZ$0.1 M39.4%
2004-12-31NZ$0.07 M28.16%
2003-12-31NZ$0.05 M288.54%
2002-12-31NZ$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cytokinetics
CYTK
NZ$2.06 B 8,129.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$0.45 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$79.08 B 314,798.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$0.73 B 2,845.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$4.52 M-81.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$0.95 M-96.20%๐Ÿ‡บ๐Ÿ‡ธ USA